Not on air · 2 of 3 networks checked
NEMERA
- nemera.net
- FR
- 1,668 employees
NEMERA’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 37. Watch NEMERA with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| None recorded | 0 | Checked 29 Oct 2026 | See all 37 ads → | ||
| Meta | Not checked | — | |||
| None recorded | 0 | No ads found on the Google Ads Transparency Center | Checked 1 Oct 2026 | Collect them with the API → |
NEMERA has no live LinkedIn ads. We recorded no Google ads on 1 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 21 Oct 2026
Preservative-free multidose ophthalmic delivery requires a careful balance between microbiological integrity, dose precision, usability and scalability. With proven worldwide adoption, Novelia® combines non-return valve technology, PureFlow® technology and platform configurability to support preservative-free ophthalmic drug delivery.
- LINKEDIN · IMAGESince 13 Oct 2026
Novelia® can accommodate a wide panel of ophthalmic formulations thanks to its modular platform approach. This modularity allows pharmaceutical partners to match drug characteristics, target markets and regulatory preferences through a range of caps, bottles, valves and PureFlow® technology.
- LINKEDIN · IMAGESince 12 Oct 2026
PenSET combines spring-assisted delivery with a pre-set dose approach, designed to support programs where usability, reliability and dose confidence are key. Developed with Nemera’s platform expertise and expert design teams, PenSET supports pharmaceutical partners looking for reliable pen injector solutions.
- LINKEDIN · IMAGESince 12 Oct 2026
PenDIA combines spring-assisted drug delivery with variable-dose flexibility, designed to support reliable injection experiences across chronic injectable therapies. Developed with Nemera’s platform expertise and expert design teams, PenDIA supports pharmaceutical partners looking for adaptable pen injector solutions.
- LINKEDIN · IMAGESince 12 Oct 2026
PenVARIO is a manual variable-dose pen injector platform designed to support a wide range of injectable therapies and program needs. With adaptable platform development and long-term CMO experience, Nemera supports pharmaceutical partners from early concept to industrialization and lifecycle management.
- LINKEDIN · IMAGESince 15 Sept 2026
Thanks to its PureFlow® technology and non-return valve system, Novelia® is designed to support the release of a single calibrated drop at each actuation, regardless of bottle fill level. Meet our teams at CPHI Milan, Booth #11A25, to learn more about our ophthalmic solutions.
6 of 37 adsSign up to see every NEMERA ad, filter by format and date, and get alerts on new ones.
See all 37 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.